Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Policy FDA layoffs could compromise safety of medications made at foreign factories, inspectors say Beyond staff cuts, the departures of some longtime investigators in recent months have left less ...

Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical ...

Marcel Botha discusses whether AI can truly be used to replace laid off human workers at FDA.